Healthcare
Based on ARK ETF real-time + 13F quarterly filings
13F data may be delayed up to 90 days.
※ Analyst opinions are for reference only and do not constitute investment advice. Each securities firm may have different opinions.
Exact Sciences Corporation is a leading provider of cancer screening and diagnostic tests. Their main products include Cologuard for colorectal cancer screening and the Oncotype DX tests for breast and colon cancer recurrence risk. The company is focused on developing innovative solutions across the entire cancer care continuum, from risk assessment to recurrence monitoring.
AI-generated summary. Not investment advice.